Current Headlines

71. BioTek Instruments Wins Governor's Award For Outstanding Workplace Safety
    4/17/2013

    The Vermont Safety & Health Council, and the Vermont Small Business Development Center recently presented BioTek with the 2013 "Governor's Award for Outstanding Workplace Safety" in the Large Business category at a ceremony in South Burlington, VT.

72. ATMI Debuts Integrity® LevMixer® 3 At INTERPHEX
    4/17/2013

    ATMI, Inc. (Nasdaq:ATMI), a global technology company and leader in single-use bioprocess solutions, today unveiled the third generation of its Integrity® LevMixer® system with full remote control capability and real-time speed reading.

73. RevElution™ Bio-Concentrator Rapidly And Efficiently Concentrates Liquid Microbial Samples For Further Analysis
    4/16/2013

    The RevElution™ Bio-Concentrator uses patented technology to rapidly and efficiently concentrate liquid microbial samples for further analysis. Samples as large as two liters may be concentrated at a rate up to 100 ml/minute using a unique method that draws the liquid through a filter then elutes the trapped particles with a wet foam solution.

74. Protector® Downdraft Powder Station Keeps Users Safe While Dusting For Fingerprints
    4/16/2013

    The Protector Downdraft Powder Stations keep users safe by containing powders during fingerprint processing. The open-sided, open-top work station provides unrestricted operator movement and accommodates oversized evidence.

75. CentriVap® Micro IR Vacuum Concentrator Uses Infrared Heat To Speed Sample Evaporation Process
    4/16/2013

    The CentriVap micro IR Vacuum Concentrator has the smallest footprint available so it fits in tight spaces and is ideal for small throughput in molecular biology, proteomics, genomic, genetics, cell biology and drug discovery labs.

76. Finesse Solutions And ATMI Sign Distribution Agreement For Turnkey Bioreactor Systems
    4/16/2013

    Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the signing of a Distribution Agreement with ATMI, Inc., a global technology company and a leader in single-use process solutions.

77. Frost & Sullivan: New Drug Candidates Hold Tremendous Promise For European HIV Drugs Market
    4/16/2013

    The anticipated launch of drugs currently in the pipeline, together with the introduction of oral combination pills, are set to have a profound impact on the European HIV drugs market.

78. Patheon to Feature its Complex Formulation Technologies Expertise
    4/15/2013

    Patheon personnel will be available to meet at the CPhI/ICSE Japan conference in Tokyo from April 24-26, 2013 to discuss how Patheon can actively support pharmaceutical and biotech companies achieve their key development and manufacturing goals

79. Innate Pharma Presents New Data For Proprietary Programs Targeting TLR3 And KIR3DL2
    4/15/2013

    Innate Pharma SA (EURONEXT PARIS: IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, announces today that new preclinical data for two proprietary programs were presented at the Molecular Pattern Recognition Receptors meeting and the American Association for Cancer Research ("AACR") annual meeting.

80. Singapore Single-Cell Research Center Opens Door For Asian Biological Discoveries
    4/15/2013

    Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore today. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.